Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis. Chemical Interactions, [S. l.], v. 2, n. 1, 2026. DOI: 10.64354/4nx8w333. Disponível em: https://cheminters.com/index.php/jci/article/view/58. Acesso em: 5 jun. 2026.